Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 24, 2021
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
[ Mon, May 24th 2021
] - WOPRAI
Fri, May 21, 2021
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
Eliana Merle Initiated (APLS) at Strong Buy and Held Target at $82 on, May 21st, 2021
Eliana Merle of UBS, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $82 on, May 21st, 2021.
Eliana has made no other calls on APLS in the last 4 months.
There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 1 agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $39 on, Thursday, April 29th, 2021
This is the rating of the analyst that currently disagrees with Eliana
- Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021
